200120172020

Unpacking rare diseases in the first edition of Delta magazine

Natasha Cowan | 16 November 2020

Hero image

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.

Welcome to Delta – the new Fishawack Health magazine.

We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases.

Rare diseases represent an incredibly high unmet need, not only due to the lack of therapies and the practical difficulties in diagnosis, but also in patients’ desire for better knowledge, communication, and more meaningful relationships with their healthcare professionals.

As our rare disease specialist agency Dudnyk says: “We are seeing a growing separation between healthcare professionals and patients. The impact of this great divide in understanding is negatively affecting the treatment experience—for both sides—as well as severely limiting the trajectory of specialty healthcare brands.”

The dynamic between patients and healthcare professionals, combined with the challenges of patient identification and data generation in tiny patient populations (made even more challenging in a global pandemic), means rare disease drug development and launch requires a unique business model.

In this edition of Delta, our consultants, creatives and medical communications experts explore the challenges and opportunities for life science companies operating in rare disease, including:

  • Navigating real-world evidence and why it could be a gamechanger in rare disease
  • A patient’s account of living with a rare disease in the COVID-19 pandemic
  • How to make an impact in small patient populations
  • The lessons Dan Zaksas, PhD, Senior Vice President, Director of Scientific and Medical Affairs at Dudnyk, has learned during a decade working in rare diseases
  • Why you need to build relationships with KOLs and patients much earlier than you think
  • The lasting implications of COVID-19 on the life science industry.

We hope you enjoy the first edition of Delta. If you would like to find out how we can help you solve a specific life science challenge, get in touch with newbusiness@fishawack.com

Fill out the form below to receive a PDF of the Delta magazine

Latest articles

ICER and Value Assessment Frameworks: 5 key insights for biopharma

30 November 2021

Fishawack Gives Back: How we’re mobilizing our teams to support philanthropic causes across the globe

23 November 2021

Addressing inequities in access to healthcare: 4 recommendations for biopharma manufacturers

16 November 2021

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement

Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on fishawack.com, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on Fishawack.com.

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.